This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 55
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The study is designed to test safety tolerability and PK of single oral ascending doses of PF-06305591,

Provided treatments

  • Drug: PF-06305591
  • Drug: Placebo
  • Drug: PF-06305591
  • Drug: Placebo
  • Drug: PF-06305591
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01747941. The sponsor of the trial is Pfizer and it is looking for 30 volunteers for the current phase.
Official trial title:
A Double Blind (3rd Party Open) Randomized, Placebo Controlled, Crossover Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects